5323312026-01-012026-03-315323312026-03-315323312025-03-315323312025-04-012026-03-315323312026-01-012026-03-31in-capmkt:OtherExpenses1Member5323312025-04-012026-03-31in-capmkt:OtherExpenses1Member5323312026-03-31OtherNoncurrentFinancialAssetsDomain15323312026-03-31OtherNoncurrentAssetsDomain15323312026-03-31OtherNoncurrentAssetsDomain25323312026-03-31OtherCurrentFinancialAssetsDomain15323312026-03-31OtherCurrentAssetsDomain15323312026-03-31OtherNoncurrentFinancialLiabilitiesDomain15323312026-03-31OtherNoncurrentFinancialLiabilitiesDomain25323312026-03-31OtherNoncurrentLiabilitiesDomain15323312026-03-31OtherCurrentFinancialLiabilitiesDomain15323312026-03-31OtherCurrentFinancialLiabilitiesDomain25323312026-03-31OtherCurrentLiabilitiesDomain15323312026-01-012026-03-31ItemsThatWillNotBeReclassifiedToProfitAndLoss15323312025-04-012026-03-31ItemsThatWillNotBeReclassifiedToProfitAndLoss15323312026-01-012026-03-31ItemsThatWillBeReclassifiedToProfitAndLoss15323312025-04-012026-03-31ItemsThatWillBeReclassifiedToProfitAndLoss15323312026-01-012026-03-31AuditorDomain1iso4217:INRiso4217:INRxbrli:shares532331AJANTPHARMNOTLISTEDINE031B01049AJANTA PHARMA LIMITEDMain BoardEquity2025-04-012026-03-312026-05-052026-04-21INRCroresQuarterlyFourth quarterSingle segmentPharmaceutical2026-05-0513:30:002026-05-0515:10:00trueCash Flow IndirectDeclaration of unmodified opinion2026-01-012026-03-31AuditedConsolidated14216400000614300000148307000002567600000713500000-233000000340720000023600000453700000442700000011359600000347110000003471100000614000000190100000804100000026670000000000266700000018110000028481000002667000000028481000000250700000221.3521.340021.3521.341. The above consolidated financial results have been reviewed by Audit Committee and approved by the Board of Directors at their meeting held on 5 May 2026. The statutory auditors have expressed an unmodified opinion on the results for the quarter and year ended 31 March 2026. The audit report has been filed with the stock exchange and is available on the company's website. <BR> 2. The figures for the quarter ended 31 March 2026 and 31 March 2025 are the balancing figures between audited figures in respect of full financial year and the unaudited published year to date figures upto the third quarter ended 31 December 2025 and 31 December 2024 respectively. <BR> 3. The consolidated audited financial results of the Company and its wholly owned subsidiaries (“the Group”) have been prepared as per Ind AS 110 on "Consolidated Financial Statements". There is no minority interest. <BR> 4. Other income / Other expense includes: Quarter ended Year ended <BR> Rs. in Crore <BR> 31-Mar-26 31-Dec-25 31-Mar-25 31-Mar-26 31-Mar-25 <BR> Foreign exchange <BR> gain (in other <BR> income) 44.37 8.55 7.06 97.17 28.21 <BR> Foreign exchange <BR> loss (in other <BR> expense) 41.70 - - 103.04 8.82 <BR> 5. During the year ended 31 March 2026, 23,525 (previous year 25,325) equity shares of Rs. 2 each, fully paid up, were allotted upon exercise of vested options pursuant to the Share Based Incentive Plan, 2019, resulting in an increase in the paid-up share capital by Rs. 47,050 (previous year Rs. 50,650) and securities premium by Rs. 3.50 crores (previous year Rs. 3.84 crores). Under the same plan, 4,300 Cash Settled Stock Appreciation Rights (SARs) were vested and settled in cash and there was no change in the paid-up share capital and securities premium of the company. <BR> 6. In August 2025, the Income Tax Authorities carried out search operations at certain premises of the Parent Company. Subsequently, the Parent Company received a notice dated 6 February 2026 under Section 158BC of the Income tax Act, 1961, requiring the Parent Company to file a true and correct return for the block period from 1 April 2019 to 17 November 2025. The Parent Company filed the return for the said block period on 6 April 2026. Pending any subsequent communication from the concerned authorities in this regard, the consequent impact on the consolidated financial results for the year ended 31 March 2026, if any, is currently not ascertainable. <BR> 2025-04-012026-03-31AuditedConsolidated5452860000017207000005624930000091651000002297900000374600000129115000001611000001731400000158312000004247280000013776500000013776500000300080000021570000032165000000105600000000000105600000002908000001085080000010560000000010850800000025070000024502020000084.5384.510084.5384.51Other Expenses4427000000Other Expenses1583120000017263500000258050000000140600000000028500000000799000003649000001885900000693300000241941000009385400000559850000018538800000103260000015100000168000008980000025291600000026773000003735430000000615484000002507000004502020000045270900000045270900000000041240000041240000051150000011794000000167000002120000000211990000054170000049013000005443000000504580000012608700000119000000030390000054900000014157500000001627750000061548400000Other non-current financial assets79900000Income tax assets (net)75600000Other non-current assets617700000Other current financial assets89800000Other current assets2677300000Non-current Lease liabilities394200000Other non-current financial liabilities18200000Other non-current liabilities16700000Current Lease liabilities87600000Other current financial liabilities4958200000Other current liabilities1190000000161100000-309500000-59084000000-1588200000000090790000005928000000173140000040800000-223900000000-581400000060300000015300000873700000000-33000000-48947000008881800000000358990000005291900000002549090000026599800000000326000005410000036516000000000000000000000004537000000-3900000-42892000000000000020940000000148000000349720000012800000000-1679200000-676500000-42100000-71860000017512000001032600000Items that will not be reclassified subsequently to profit or loss3510000035100000Items that will not be reclassified subsequently to profit or loss-4800000-480000012300000-1700000Items that will be reclassified subsequently to profit or loss158300000158300000Items that will be reclassified subsequently to profit or loss29390000029390000000181100000290800000AuditedtrueB S R & Co. LLPtrue2025-07-31